Ryan K. Flannigan, MD, FRCSC, highlights a phase 2 study of the sustained-release lidocaine formulation ST-01 as a potential nonsurgical treatment for chronic scrotal content pain.
Ryan K. Flannigan, MD, FRCSC
Advertisement
Articles by Ryan K. Flannigan, MD, FRCSC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
BOND-003 Cohort C: Efficacy Results
4
Laura Bukavina, MD, and Gabriela Díaz, MD, on the rise of young-onset bladder cancer
5